In a two-center study of lung cancer surgery patients, investigators found that CRP (and IL-6) levels rose in all patients postoperatively, including those who never developed any infection, meaning the markers’ additional predictive value was limited in the very early period. This evidence concerns the gene CRP and lung carcinoma.